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INTRODUCTION
Interferential current (IFC) is widely used in 
conjunction with other therapies to manage 
musculoskeletal pain. IFC uses two medium 
frequency carrier currents which interfere deeper in 
tissues, producing an amplitude modulated 
frequency (AMF). The interference creates the effect 
of low frequency stimulation with less discomfort for 
patients compared to direct low frequency 
stimulation. The predominant proposed mechanisms 
of analgesia include the gate control theory of pain 
and endogenous opioid production. Since previous 
systematic reviews have found a lack of studies 
examining the independent treatment effects of IFC, 
this study reviewed the isolated effects of IFC 
compared to control groups. 
PURPOSE
The purpose of this study was to conduct a 
systematic review of existing literature addressing 
the potential effectiveness of IFC as an adjunctive 
biophysical agent for treating musculoskeletal pain.
METHODS
CINAHL, PubMed, Cochrane Library, PEDro, 
SportDISCUS, and CENTRAL were searched 
between November 2016 and February 2017 with 
the following terms: interferential current, 
interferential therapy, interferential electrical 
stimulation, pain, and analgesia. Articles met 
inclusion criteria if they were randomized controlled 
trials (RCT) that had IFC as an intervention and an 
assessment of pain as an outcome measure. 
Studies were excluded if they were duplications, had 
a publication date prior to 2009, were not published 
in English, used thermal induced pain in healthy 
subjects, if the effects of IFC were not tested in 
isolation of other treatments, or if no form of a 
control group was used. 
RESULTS
The initial search yielded 285 results with 10 eligible 
studies adhering to inclusion and exclusion criteria, 
published from 2011-2016. Participants across 
studies included healthy individuals with 
experimentally induced pain and patients with the 
following diagnoses: chronic low back pain, carpal 
tunnel syndrome, shoulder hemiplegia, and knee 
osteoarthritis. Outcome measures included 
subjective pain reports such as the visual analog 
scale (VAS) or the numeric pain rating scale, 
objective physiological measurements such as 
pain-free ROM or a 15 meter walk test, pain 
behavior assessments such as medication use, and 
functional outcome measures such as the 
Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC). These 10 studies 
were analyzed with a PEDro scale: scores ranged 
from five through nine, with a mean value of seven. 
All nine RCTs that used a carrier frequency of 4,000 
Hz reported a positive effect of IFC: seven reported 
a reduction in a measure of pain and two reported a 
decrease in use of pain medication. One RCT 
reported no significant effect of IFC when using a 
carrier frequency of 2,000 Hz. Four of the 10 RCTs 
evaluated long-term effects: three RCTs found 
significant lasting benefits, while one RCT found no 
significant long term improvements.
DISCUSSION
In this systematic review, including 10 randomized 
controlled trials, totaling 898 participants, IFC was 
found to be effective in the immediate management 
of musculoskeletal pain. 
Carrier frequency, as opposed to AMF, may be the 
more dominant analgesic parameter. Four thousand 
Hz is the most commonly used carrier frequency. All 
studies included that used a carrier frequency of 
4,000 Hz reported an immediate reduction in pain or 
a decrease in use of pain medication. Pereira et al,1 
when using a carrier frequency of 2,000 Hz, found 
that IFC did not significantly alter pain pressure 
threshold, and in fact, reduced pain threshold to 
cold. Correa et al2 reported that both the 1,000 and 
4,000 Hz groups had no significant alterations in 
pain intensity, but did have significantly lower rates 
of pain medication usage. In addition, the 1,000 Hz 
group had significant improvement on the 
physiological pain parameters of temporal 
summation and pain pressure threshold (PPT). 
Therefore, while a carrier frequency of 4,000 Hz has 
been shown to be effective for pain management, 
further studies are warranted to examine the 
effectiveness of other carrier frequencies. 
Despite a lack of evidence, many authors regard 
AMF as the most relevant IFC parameter. Gundog 
et al3 compared the effectiveness of different AMFs 
and found no significantly different analgesic effects. 
Future research addressing the potential physiologic 
effects of varying the AMF and the associated 
clinical implications is needed.
Long term follow-ups had mixed results. Three 
studies3-5 found significant improvements at three 
weeks, one month, and six months, respectively. 
One study2 found no significant difference at four 
months. Further research regarding both the long 
term effectiveness and the immediate duration of 
pain relief based on various IFC parameters is 
needed.
Author, Year Study Design PEDro Score
Number of 
Participants
Patient 
Population Trial Groups
Treatment 
Duration
Outcome 
Measures Key Findings
Correa et al, 2016 Parallel RCT 9 150 CLBP IFC: Placebo, 1 kHz, 4 kHz 12 sessions x 30 
minutes
ii, iv, v, vi, vii, xv, 
xviii
There was no significant difference between groups for pain intensity 
at rest or with movement, but both treatment groups had significantly 
lower frequeny of pain medication usage. The 1 kHz IFC group had 
significantly improved pressure pain threshold and temporal 
summation. There was no significant difference between the groups 
at 4 month follow up.
Fuentes et al, 2014 Parallel RCT 8 117 CLBP
IFC: Placebo (limited TA, 
enhanced TA), Frequency not 
reported (limited TA, 
enhanced TA)
1 session x 30 
minutes
iv, vi, xxiii, xxi, 
xxii
IFC significantly reduced pain intensity and pressure pain threshold. 
Enhanced therapeutic alliance significantly increases the positive 
effects of IFC.
Koca et al, 2014 Parallel RCT 5 75 CTS
IFC: 4 kHz
TENS: 100 Hz 
Splint therapy: worn during 
night sleep
IFC & TENS: 15 
sessions x 20 
minutes
Splint therapy: 3 
weeks
vii, x, xii, xiii-a, 
xiii-b
IFC was significantly more effective than splint therapy for the 
following measures: VAS, mMDL, and mSNCV. IFC was significantly 
more effective than TENS for the following measures: VAS, symptom 
severity, functional capacity, mMDCL, and mSNCV. Outcome 
measures were evaluated three weeks post-treatment completion.
Suriya-amarit et al, 
2014
Parallel, 
matched-pair 
RCT
6 30 Shoulder 
hemiplegia
IFC: Placebo, 4 kHz 1 session x 20 
minutes
iv, v, xii IFC significantly reduced pain during movement and increased pain-
free PROM for shoulder flexion, abduction, IR, and ER.
Atamaz et al, 2012 Parallel RCT 9 203 Knee OA
IFC: Placebo, 4 kHz
TENS:Placebo, 80 Hz
SWD: Placebo, 27.12 MHz,
15 sessions x 20 
minutes
vii, ix, xv, xvi, 
xix, xx, xxv
All treatment groups had signitificant decreases in pain 
assessments. The IFC treatment group had significantly lower 
paracetamol intake at 1, 3, and 6 months with no other significant 
differences between groups.
Gundog et al, 2012 Parallel RCT 6 60 Knee OA
IFC: Placebo, AMF 40 Hz, 
AMF 100 Hz, AMF 180 Hz
[Carrier freq. 4 kHz]
15 sessions x 20 
minutes
vi-a, vi-b, vi-c, 
ix, xiii, xv, xxiv, 
xx-a, xx-b, xx-
c, xix
All treatment groups had significant improvements on all outcome 
measures except for knee AROM. These improvements remained 
significant at 1 month follow up. There was no significant difference in 
improvement between the treatment groups.
Rocha et al, 2012 Parallel RCT 5 41
Healthy, DOMS 
induced IFC: Placebo, 4 kHz
1 session x 30 
minutes vi, viii
IFC significantly increased pressure pain threshold. There was no 
significant difference between groups for isometric peak torque.
Facci et al, 2011 Parallel RCT 7 150 CLBP
IFC: 4 kHz
TENS: 20 Hz
No treatment
10 sessions x 30 
minutes
i-a, i-b, i-c, iii, 
vii, xv, xvii
IFC was significantly more effective at reducing pain, disability, and 
medicine usage than controls. There was no significant difference 
between IFC and TENS.
Fuentes et al, 2011 Crossover RCT 7 40
Healthy, 
pressure induced
IFC: Placebo, 4 kHz
No treatment
3 sessions x 30 
minutes vi IFC significantly decreased pressure pain threshold.
Pereira et al, 2011 Crossover RCT 5 14
Healthy, 
pressure & 
temperature 
induced
IFC: 2 kHz
No treatment
1 session x 15 
minutes ii, vii, vii
IFC significantly reduced the pain threshold to cold. There was no 
significant difference between groups for pressure pain threshold.
Table 1. Study Characteristics
Abbreviations: CLBP, chronic low back pain; CTS, carpal tunnel syndrome; DOMS, delayed onset muscle soreness; OA, osteoarthritis; TA, therapeutic alliance.
i Brazilian McGill Pain Questionnaire xiv Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)
ii Conditioned Pain Modulation xv Medication Use
iii Duration of Analgesia xvi Nottingham Health Profile (NHP)
iv Numeric Rating Scale (pain intensity at rest) xvii Roland Morris Disability Questionnaire (RMDQ)
v Numeric Rating Scale (pain intensity with movement) xviii Sit to Stand
vi Pain Pressure Threshold xix Time to Walk 15 Meters
vii Visual Analog Scale (VAS) xx Western Ontario and McMasters Osteoarthritis Index (WOMAC)
viii Hamstring Isometric Peak Torque xxi Credibility and Expectancy Questionnaire (CEQ)
ix Knee Active ROM xxii Global Rating Scale
x Median Nerve Motor Distal Latency (mMDL) xxiii Pain Rehabilitation Expectations Scale (PRES)
xi Median Sensory Nerve Conduction Velocity (mSNCV) xxiv Treatment Effectiveness
xii Pain-Free Passive ROM xxv VAS of Satisfaction of Treatment Experience
xiii Swelling and Synovial Effusion
Table 2. Outcome Measures
Pain Activities and Participation
Body Structures and Function Treatment Evaluation
CONCLUSIONS
The reviewed studies support use of IFC in the 
treatment of musculoskeletal pain. More research is 
needed to determine the optimal parameters and 
evaluate long-term effectiveness. 
CLINICAL RELEVANCE
Current evidence supports utilization of IFC as an 
effective adjunctive tool for in-clinic palliative 
intervention in the short-term management of 
musculoskeletal pain, which may help improve 
functional outcomes and reduce patient use of pain 
medications.
Figure. Application of IFC
